On the clinical implications of β-lactam-aminoglycoside synergism: Author's reply

Ronit Marcus; Leonard Leibovici; Mical Paul

doi:10.1016/j.ijantimicag.2011.04.005

On the clinical implications of β-lactam-aminoglycoside synergism: Author's reply

Ronit Marcus, Leonard Leibovici, Mical Paul

Clinical Departments

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	186
Number of pages	1
Journal	International Journal of Antimicrobial Agents
Volume	38
Issue number	2
DOIs	https://doi.org/10.1016/j.ijantimicag.2011.04.005
State	Published - Aug 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ijantimicag.2011.04.005

Cite this

@article{3ab78dab1e924a6ea1c60fb0bdf0d7b3,

title = "On the clinical implications of β-lactam-aminoglycoside synergism: Author's reply",

author = "Ronit Marcus and Leonard Leibovici and Mical Paul",

year = "2011",

month = aug,

doi = "10.1016/j.ijantimicag.2011.04.005",

language = "אנגלית",

volume = "38",

pages = "186",

journal = "International Journal of Antimicrobial Agents",

issn = "0924-8579",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - On the clinical implications of β-lactam-aminoglycoside synergism

T2 - Author's reply

AU - Marcus, Ronit

AU - Leibovici, Leonard

AU - Paul, Mical

PY - 2011/8

Y1 - 2011/8

UR - http://www.scopus.com/inward/record.url?scp=79959737699&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2011.04.005

DO - 10.1016/j.ijantimicag.2011.04.005

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

AN - SCOPUS:79959737699

VL - 38

SP - 186

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 2

ER -

On the clinical implications of β-lactam-aminoglycoside synergism: Author's reply

UN SDGs

Access to Document

Other files and links

Cite this